In-Vitro Diagnostics Market: Trends, Opportunities and Competitive Analysis [2023-2028]
2 – 3 business days by ordering today
In-Vitro Diagnostics Market Trends and Forecast
The future of the in-vitro diagnostics market looks promising with opportunities in the hospitals, laboratories, and home care end use industries. The global in-vitro diagnostics market is expected to reach an estimated $127.3 billion by 2028 with a CAGR of 5.0% from 2023 to 2028. The major drivers for this market are increasing prevalence of chronic diseases and growing demand for automated IVD systems for laboratories as well as hospitals to deliver accurate, error-free, and efficient diagnoses.
In-Vitro Diagnostics Market by Product, Application, Technology, End Use Industry, and Region
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
In-Vitro Diagnostics Market by Segments
In-Vitro Diagnostics Market by Segment
The study includes trends and forecast for the global in-vitro diagnostics market by product, application, technology, end use industry, and region, as follows:
In-Vitro Diagnostics Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Instruments
Reagents
Services
In-Vitro Diagnostics Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing
Others
In-Vitro Diagnostics Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
Immunoassay
Instruments
Reagents
Services
Hematology
Instruments
Reagents
Services
Clinical Chemistry
Instruments
Reagents
Services
Molecular Diagnostics
Instruments
Reagents
Services
Coagulation
Instruments
Reagents
Services
Microbiology
Instruments
Reagents
Services
Others
Instruments
Reagents
Services
In-Vitro Diagnostics Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Hospitals
Laboratories
Home Care
Others
In-Vitro Diagnostics Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of In-Vitro Diagnostics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, in-vitro diagnostics companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-vitro diagnostics companies profiled in this report include-
Abbott
bioM?rieux
Bio-Rad
Siemens Healthineers
Qiagen
In-Vitro Diagnostics Market Insights
Lucintel forecast that infectious diseases will remain the largest segment over the forecast period due to growing number of life-threatening diseases, such as HIV/AIDS, tuberculosis, diphtheria, hepatitis, and pneumonia.
Laboratories are expected to remain the largest segment due to the growing awareness about personalized medicine and the availability of technologically advanced equipment.
North America will remain the largest region due presence of well-established healthcare infrastructure, rising geriatric population, and an increase in healthcare expenditure.
Features of the In-Vitro Diagnostics Market
Market Size Estimates: In-vitro diagnostics market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: In-vitro diagnostics market size by various segments, such as product, application, technology, end use industry, and region
Regional Analysis: In-vitro diagnostics market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different products, applications, technology, end use industries, and regions for the in-vitro diagnostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the in-vitro diagnostics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the in-vitro diagnostics market size?
Answer: The global in-vitro diagnostics market is expected to reach an estimated $127.3 billion by 2028.
Q2. What is the growth forecast for in-vitro diagnostics market?
Answer: The global in-vitro diagnostics market is expected to grow with a CAGR of 5.0% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the in-vitro diagnostics market?
Answer: The major drivers for this market are increasing prevalence of chronic diseases and growing demand for automated IVD systems for laboratories as well as hospitals to deliver accurate, error-free, and efficient diagnoses.
Q4. What are the major segments for in-vitro diagnostics market?
Answer: future of the in-vitro diagnostics market looks promising with opportunities in hospitals, laboratories, home care, and others.
Q5. Who are the key in-vitro diagnostics companies?
Answer: Some of the key in-vitro diagnostics companies are as follows:
Abbott
bioM?rieux
Bio-Rad
Siemens Healthineers
Qiagen
Q6. Which in-vitro diagnostics segment will be the largest in future?
Answer: Lucintel forecast that infectious diseases will remain the largest segment over the forecast period due to growing number of life-threatening diseases, such as HIV/AIDS, tuberculosis, diphtheria, hepatitis, and pneumonia.
Q7. In in-vitro diagnostics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to presence of well-established healthcare infrastructure, rising geriatric population, and an increase in healthcare expenditure.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the in-vitro diagnostics market by product (instruments, reagents, and services), application (infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, drug testing, others), technology (immunoassay, hematology, clinical chemistry), molecular diagnostics, coagulation, microbiology, and others), end use industry (hospitals, laboratories, home care, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to in-vitro diagnostics market or related to in-vitro diagnostics companies, in-vitro diagnostics market size, in-vitro diagnostics market share, in-vitro diagnostics analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
In-Vitro Diagnostics Market Trends and Forecast
The future of the in-vitro diagnostics market looks promising with opportunities in the hospitals, laboratories, and home care end use industries. The global in-vitro diagnostics market is expected to reach an estimated $127.3 billion by 2028 with a CAGR of 5.0% from 2023 to 2028. The major drivers for this market are increasing prevalence of chronic diseases and growing demand for automated IVD systems for laboratories as well as hospitals to deliver accurate, error-free, and efficient diagnoses.
In-Vitro Diagnostics Market by Product, Application, Technology, End Use Industry, and Region
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
In-Vitro Diagnostics Market by Segments
In-Vitro Diagnostics Market by Segment
The study includes trends and forecast for the global in-vitro diagnostics market by product, application, technology, end use industry, and region, as follows:
In-Vitro Diagnostics Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Instruments
Reagents
Services
In-Vitro Diagnostics Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing
Others
In-Vitro Diagnostics Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
Immunoassay
Instruments
Reagents
Services
Hematology
Instruments
Reagents
Services
Clinical Chemistry
Instruments
Reagents
Services
Molecular Diagnostics
Instruments
Reagents
Services
Coagulation
Instruments
Reagents
Services
Microbiology
Instruments
Reagents
Services
Others
Instruments
Reagents
Services
In-Vitro Diagnostics Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Hospitals
Laboratories
Home Care
Others
In-Vitro Diagnostics Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of In-Vitro Diagnostics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, in-vitro diagnostics companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-vitro diagnostics companies profiled in this report include-
Abbott
bioM?rieux
Bio-Rad
Siemens Healthineers
Qiagen
In-Vitro Diagnostics Market Insights
Lucintel forecast that infectious diseases will remain the largest segment over the forecast period due to growing number of life-threatening diseases, such as HIV/AIDS, tuberculosis, diphtheria, hepatitis, and pneumonia.
Laboratories are expected to remain the largest segment due to the growing awareness about personalized medicine and the availability of technologically advanced equipment.
North America will remain the largest region due presence of well-established healthcare infrastructure, rising geriatric population, and an increase in healthcare expenditure.
Features of the In-Vitro Diagnostics Market
Market Size Estimates: In-vitro diagnostics market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: In-vitro diagnostics market size by various segments, such as product, application, technology, end use industry, and region
Regional Analysis: In-vitro diagnostics market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different products, applications, technology, end use industries, and regions for the in-vitro diagnostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the in-vitro diagnostics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the in-vitro diagnostics market size?
Answer: The global in-vitro diagnostics market is expected to reach an estimated $127.3 billion by 2028.
Q2. What is the growth forecast for in-vitro diagnostics market?
Answer: The global in-vitro diagnostics market is expected to grow with a CAGR of 5.0% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the in-vitro diagnostics market?
Answer: The major drivers for this market are increasing prevalence of chronic diseases and growing demand for automated IVD systems for laboratories as well as hospitals to deliver accurate, error-free, and efficient diagnoses.
Q4. What are the major segments for in-vitro diagnostics market?
Answer: future of the in-vitro diagnostics market looks promising with opportunities in hospitals, laboratories, home care, and others.
Q5. Who are the key in-vitro diagnostics companies?
Answer: Some of the key in-vitro diagnostics companies are as follows:
Abbott
bioM?rieux
Bio-Rad
Siemens Healthineers
Qiagen
Q6. Which in-vitro diagnostics segment will be the largest in future?
Answer: Lucintel forecast that infectious diseases will remain the largest segment over the forecast period due to growing number of life-threatening diseases, such as HIV/AIDS, tuberculosis, diphtheria, hepatitis, and pneumonia.
Q7. In in-vitro diagnostics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to presence of well-established healthcare infrastructure, rising geriatric population, and an increase in healthcare expenditure.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the in-vitro diagnostics market by product (instruments, reagents, and services), application (infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, drug testing, others), technology (immunoassay, hematology, clinical chemistry), molecular diagnostics, coagulation, microbiology, and others), end use industry (hospitals, laboratories, home care, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to in-vitro diagnostics market or related to in-vitro diagnostics companies, in-vitro diagnostics market size, in-vitro diagnostics market share, in-vitro diagnostics analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL IN-VITRO DIAGNOSTICS MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global In-Vitro Diagnostics Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global In-Vitro Diagnostics Market by Application
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Services
3.4: Global In-Vitro Diagnostics Market by Application
3.4.1: Infectious Diseases
3.4.2: Diabetes
3.4.3: Oncology
3.4.4: Cardiology
3.4.5: Nephrology
3.4.6: Autoimmune Diseases
3.4.7: Drug Testing
3.4.8: Others
3.5: Global In-Vitro Diagnostics Market by Technology
3.5.1: Immunoassay
3.5.1.1: Instruments
3.5.1.2: Reagents
3.5.1.3: Services
3.5.2: Hematology
3.5.2.1: Instruments
3.5.2.2: Reagents
3.5.2.3: Services
3.5.3: Clinical Chemistry
3.5.3.1: Instruments
3.5.3.2: Reagents
3.5.3.3: Services
3.5.4: Molecular Diagnostics
3.5.4.1: Instruments
3.5.4.2: Reagents
3.5.4.3: Services
3.5.5: Coagulation
3.5.5.1: Instruments
3.5.5.2: Reagents
3.5.5.3: Services
3.5.6: Microbiology
3.5.6.1: Instruments
3.5.6.2: Reagents
3.5.6.3: Services
3.5.7: Others
3.5.7.1: Instruments
3.5.7..2: Reagents
3.5.7.3: Services
3.6: Global In-Vitro Diagnostics Market by End Use Industry
3.6.1: Hospitals
3.6.2: Laboratories
3.6.3: Home Care
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global In-Vitro Diagnostics Market by Region
4.2: North American In-Vitro Diagnostics Market
4.2.1: North American In-Vitro Diagnostics Market by Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.2.2: North American In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
4.3: European In-Vitro Diagnostics Market
4.3.1: European In-Vitro Diagnostics Market by Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.3.2: European In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
4.4: APAC In-Vitro Diagnostics Market
4.4.1: APAC In-Vitro Diagnostics Market by Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.4.2: APAC In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
4.5: ROW In-Vitro Diagnostics Market
4.5.1: ROW In-Vitro Diagnostics Market by Application: : Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.5.2: ROW In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global In-Vitro Diagnostics Market by Product
6.1.2: Growth Opportunities for the Global In-Vitro Diagnostics Market by Application
6.1.3: Growth Opportunities for the Global In-Vitro Diagnostics Market by Technology
6.1.4: Growth Opportunities for the Global In-Vitro Diagnostics Market by End Use Industry
6.1.5: Growth Opportunities for the Global In-Vitro Diagnostics Market by Region
6.2: Emerging Trends in the Global In-Vitro Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global In-Vitro Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Vitro Diagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Abbott
7.2: bioM?rieux
7.3: Bio-Rad
7.4: Siemens Healthineers
7.5: Qiagen
2. GLOBAL IN-VITRO DIAGNOSTICS MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global In-Vitro Diagnostics Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global In-Vitro Diagnostics Market by Application
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Services
3.4: Global In-Vitro Diagnostics Market by Application
3.4.1: Infectious Diseases
3.4.2: Diabetes
3.4.3: Oncology
3.4.4: Cardiology
3.4.5: Nephrology
3.4.6: Autoimmune Diseases
3.4.7: Drug Testing
3.4.8: Others
3.5: Global In-Vitro Diagnostics Market by Technology
3.5.1: Immunoassay
3.5.1.1: Instruments
3.5.1.2: Reagents
3.5.1.3: Services
3.5.2: Hematology
3.5.2.1: Instruments
3.5.2.2: Reagents
3.5.2.3: Services
3.5.3: Clinical Chemistry
3.5.3.1: Instruments
3.5.3.2: Reagents
3.5.3.3: Services
3.5.4: Molecular Diagnostics
3.5.4.1: Instruments
3.5.4.2: Reagents
3.5.4.3: Services
3.5.5: Coagulation
3.5.5.1: Instruments
3.5.5.2: Reagents
3.5.5.3: Services
3.5.6: Microbiology
3.5.6.1: Instruments
3.5.6.2: Reagents
3.5.6.3: Services
3.5.7: Others
3.5.7.1: Instruments
3.5.7..2: Reagents
3.5.7.3: Services
3.6: Global In-Vitro Diagnostics Market by End Use Industry
3.6.1: Hospitals
3.6.2: Laboratories
3.6.3: Home Care
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global In-Vitro Diagnostics Market by Region
4.2: North American In-Vitro Diagnostics Market
4.2.1: North American In-Vitro Diagnostics Market by Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.2.2: North American In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
4.3: European In-Vitro Diagnostics Market
4.3.1: European In-Vitro Diagnostics Market by Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.3.2: European In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
4.4: APAC In-Vitro Diagnostics Market
4.4.1: APAC In-Vitro Diagnostics Market by Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.4.2: APAC In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
4.5: ROW In-Vitro Diagnostics Market
4.5.1: ROW In-Vitro Diagnostics Market by Application: : Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others
4.5.2: ROW In-Vitro Diagnostics Market by End Use Industry: Hospitals, Laboratories, Home Care, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global In-Vitro Diagnostics Market by Product
6.1.2: Growth Opportunities for the Global In-Vitro Diagnostics Market by Application
6.1.3: Growth Opportunities for the Global In-Vitro Diagnostics Market by Technology
6.1.4: Growth Opportunities for the Global In-Vitro Diagnostics Market by End Use Industry
6.1.5: Growth Opportunities for the Global In-Vitro Diagnostics Market by Region
6.2: Emerging Trends in the Global In-Vitro Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global In-Vitro Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Vitro Diagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Abbott
7.2: bioM?rieux
7.3: Bio-Rad
7.4: Siemens Healthineers
7.5: Qiagen
